Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biostar Pharmaceutic (BSPM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 3,884
  • Shares Outstanding, K 2,660
  • Annual Sales, $ 2,380 K
  • Annual Income, $ -5,700 K
  • 36-Month Beta 1.66
  • Price/Sales 1.61
  • Price/Cash Flow 0.00
  • Price/Book 0.10

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.35 +6.17%
on 06/21/17
1.77 -19.02%
on 06/26/17
+0.04 (+3.12%)
since 06/20/17
3-Month
1.20 +19.44%
on 06/16/17
2.00 -28.33%
on 04/25/17
-0.42 (-22.52%)
since 04/20/17
52-Week
1.20 +19.44%
on 06/16/17
7.06 -79.70%
on 10/11/16
-2.55 (-63.99%)
since 07/20/16

Most Recent Stories

More News
Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016

Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and...

BSPM : 1.43 (-2.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule,...

See More

Support & Resistance

2nd Resistance Point 1.61
1st Resistance Point 1.53
Last Price 1.43
1st Support Level 1.40
2nd Support Level 1.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.